IsoPlexis will use four new NIH grants to advance research and development of immunotherapies to treat solid tumors, bone marrow disease, autoimmune diseases and infectious diseases. Branford, Conn.—IsoPlexis Corporation (IsoPlexis), a privately held life sciences company at the forefront of single-cell analytics technology and the immune-based cancer treatment revolution, announced today that it has received […]

MADISON, WI USA A modular automated liquid handling and purification system developed by Promega Corporation for its Maxwell® nucleic acid preparation offersgives labs new found flexibility compared to large all-in-one instruments. The configurable system, which launched this week, works with existing Promega Maxwell® RSC instruments with a software upgrade and introduces two new components: The […]

IRVINE, Calif. — The Zymo Research Corp. Board of Directors has announced the appointment of Dr. Jonathan Eisen, Biologist, to its Scientific Advisory Board, effective immediately. Dr. Jonathan Andrew Eisen currently works at the University of California, Davis. He holds appointments in the Department of Evolution and Ecology in the College of Biological Sciences and in the Department of Medical […]

Studies at AMP 2017 demonstrate unique user experiences and high performance of new assays and workflows for multiple sample types Hilden, Germany, and Germantown, Maryland – QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced new studies highlighting the outstanding analytical performance and ease of use of the GeneReader NGS System, the world’s first complete […]

Dolomite Bio is delighted to announce the launch of the game-changing Nadia single cell platform, a groundbreaking system set to escalate scRNA-Seq to new heights, offering the fast-growing single cell research sector an innovative solution for a wide range of potential applications. This novel product family will be on display from the 9th to the 10th of […]

CAMBRIDGE, England Global Gene Corp today announced a collaboration with The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James), Department of Radiation Oncology, to develop a better understanding of rare cancers in South Asian and Indian populations. The collaboration with the OSUCCC – James […]

PARIS—Scipio bioscience, a Paris-based biotechnology company devoted to providing a novel sample preparation solution for single-cell studies in the form of benchtop kits, announces today the completion of its initial fundraising. A total of €1.2m has been obtained from two European seed funds: Paris, France-based Seventure Partners’ Quadrivium I seed fund and Bonn, Germany-based High-Tech […]

SAN FRANCISCO — Fluxion Biosciences, a leading developer of automated solutions for cellular analysis in life sciences research and drug discovery, today announced that it has signed a distribution agreement with Harvard Biosciences. The https://www.baratron.com/ – photo distribution agreement covers Fluxion’s BioFlux™ and IonFlux™ platforms for sale to Harvard Bioscience’s customers in North America. Fluxion’s BioFlux system is […]

LGC, the international life sciences company, today announced that it has appointed Emma Millican as Global NGS Business Unit Manager and Dr. Harold Swerdlow as Head of NGS Technology Development for their recently established Next Generation Sequencing Business Unit as part of their expanding Genomics division. These appointments further strengthen LGC’s in-house expertise to help drive […]

First-to-market reagents enable native gene overexpression for meaningful gain-of-function studies Available in multiple formats to support a wide range of applications   Cambridge, UK: Horizon Discovery (LSE: HZD) (“Horizon” or the “Company”), a global leader in gene editing and gene modulation technologies, today announced the launch of its reagent platform for CRISPR activation (CRISPRa) from its recently […]